drugset / Trial / NCT03445897
Miltefosine Plus IL Pentamidine for Bolivian CL
NaSingle-groupOpen-labelTreatment
Summary
Bolivian cutaneous leishmaniasis due to Leishmania braziliensis was treated with the combination of miltefosine (150 mg/day for 28 days) plus intralesional pentamidine (120 ug/mm2 lesion area on days 1, 3, and 5).
Timeline
- Start
- 2016-01-31
- Primary completion
- 2018-01-31
- Completion
- 2018-02-21
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Miltefosine | Small molecule | 150 mg | — |
| Subject | Pentamidine | Unknown | 120 unknown | Other |